Evolent Health (EVH) PT Lowered to $11 at Citizens; 2025 a 'Trough Earnings Year'
Tweet Send to a Friend
Citizens analyst Constantine Davides lowered the price target on Evolent Health (NYSE: EVH) to $11.00 (from $13.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
